HB 2222

  • Tennessee House Bill
  • 113th Regular Session (2023-2024)
  • Introduced in House Jan 29, 2024
  • House
  • Senate
  • Governor

DNA and Genetic Testing - As enacted, requires the department of health to conduct a review and issue a report to the general assembly on variants of the apolipoprotein L1 (APOL1) gene associated with increased risk of end-stage renal disease. - Amends TCA Title 68, Chapter 5.

Votes


Actions


May 09, 2024

House

Comp. became Pub. Ch. 838

Apr 18, 2024

House

Sponsor(s) Added.

House

Comp. SB subst.

Apr 16, 2024

House

Sponsor(s) Added.

Apr 11, 2024

House

H. Placed on Regular Calendar for 4/16/2024

Apr 10, 2024

House

Placed on cal. Calendar & Rules Committee for 4/11/2024

Apr 03, 2024

House

Sponsor(s) Added.

House

Rec. for pass. if am., ref. to Calendar & Rules Committee

Mar 27, 2024

House

Placed on cal. Health Committee for 4/3/2024

Mar 26, 2024

House

Rec for pass if am by s/c ref. to Health Committee

Mar 20, 2024

House

Action Def. in s/c Health Subcommittee to 3/26/2024

House

Placed on s/c cal Health Subcommittee for 3/26/2024

Mar 13, 2024

House

Placed on s/c cal Health Subcommittee for 3/19/2024

Jan 31, 2024

House

Assigned to s/c Health Subcommittee

House

P2C, ref. to Health Committee

Jan 29, 2024

House

Intro., P1C.

Jan 26, 2024

House

Filed for introduction

Bill Text

Bill Text Versions Format
Current Version PDF
Amendment HA0962 PDF
Amendment SA0981 PDF

Related Documents

Document Format
Fiscal Memo for HA0962 (17788)
Fiscal Note

Sources

Data on Open States is updated periodically throughout the day from the official website of the Tennessee General Assembly.

If you notice any inconsistencies with these official sources, feel free to file an issue.